COmedication Study Assessing Mono- and cOmbination Therapy With Levodopa-carbidopa inteStinal Gel

Study Identifier
P16-831
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete

Results Available

Protocol
Available Language(s): English
Statistical Analysis Plan
Available Language(s): English
Scientific Result Summary
Available Language(s): English

Study Details

Medical Condition
  • Parkinson's Disease
  • Study Drug
    N/A
    Phase
    N/A
    Sex
    Female & Male
    Age
    18+ years

    Protocol Summary

    The purpose of this study is to evaluate treatment of advanced Parkinson's Disease (PD) patients on levodopa-carbidopa intestinal gel (LCIG) monotherapy in a routine clinical setting.

    Study Locations

    Location
    Status
    Location
    Gailtal Klinik /ID# 202505
    Hermagor-Pressegger See, Carinthia, Austria, 9620
    Status
    Not applicable
    Location
    Medizinische Universität Graz /ID# 202559
    Graz, Styria, Austria, 8010
    Status
    Not applicable
    Location
    University of Calgary /ID# 206550
    Calgary, Alberta, Canada, T2N 4Z6
    Status
    Not applicable
    Location
    Ottawa Hospital /ID# 169448
    Ottawa, Ontario, Canada, K1Y 4E9
    Status
    Not applicable
    Location
    Toronto Western Hospital /ID# 169038
    Toronto, Ontario, Canada, M5T 2S8
    Status
    Not applicable
    Location
    Clinique Neuro Levis /ID# 206549
    Lévis, Quebec, Canada, G6W 0M5
    Status
    Not applicable
    Showing {first} - {last} of {total} Results